Massachusetts' effort to publicize prices is the most comprehensive so far. But some say it's more important for patients to have information on the quality of care.
The state is the first to let voters decide whether to make experimental drugs available to terminally ill patients -- a growing movement that started in a few state legislatures this year.
A ballot measure to give regulators the power to reject excessive premium hikes has garnered opposition from an organization that aims to make insurance more affordable.
A change at the top this November could dramatically change the chances for Medicaid expansion in several states.
